Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.99K Sell
396
-1
-0.3% -$23 ﹤0.01% 1958
2026
Q1
$9.25K Buy
397
+43
+12% +$926 ﹤0.01% 1885
2025
Q4
$7.08K Buy
354
+106
+43% +$2.07K ﹤0.01% 1934
2025
Q3
$4.53K Buy
248
+60
+32% +$1.17K ﹤0.01% 1900
2025
Q2
$3.78K Hold
188
﹤0.01% 1897
2025
Q1
$3.41K Buy
188
+78
+71% +$1.4K ﹤0.01% 1856
2024
Q4
$1.91K Hold
110
﹤0.01% 1951
2024
Q3
$2.12K Buy
110
+49
+80% +$903 ﹤0.01% 1968
2024
Q2
$1K Buy
61
+35
+135% +$543 ﹤0.01% 1971
2024
Q1
$396 Buy
+26
New +$408 ﹤0.01% 2038

Other funds holding INVA

UMB Bank's INVA Position: Q2 2026 in Review

UMB Bank reduced its Innoviva (INVA) stake by 0.25% in Q2 2026, selling an estimated $23 and leaving 396 shares worth $8.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1958.

UMB Bank first reported a position in INVA in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.25K in Q1 2026. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • UMB Bank held 396 shares of Innoviva worth $8.99K as of Q2 2026.
  • UMB Bank sold 1 Innoviva share in Q2 2026, an estimated $23.
  • Innoviva made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1958 holding.
  • UMB Bank first reported a position in Innoviva in Q1 2024 and has held it in 10 quarters since.
  • UMB Bank's Innoviva position peaked at $9.25K in Q1 2026.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.